HLA-B and leprosy: Furthermore, HLA-B*13:01 testing is recommended for new patients with leprosy being initiated on dapsone therapy in China (Liu et al., 2019); an ongoing clinical trial is examining the efficacy of CYP2C9*3 and HLA-B alleles screening to prevention of phenytoin-induced SCAR in China population (Chang et al., 2020).